Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

Clinical trial NCT05636852 · TERMINATED

Trial details

NCT number: NCT05636852
Sponsor: GE Healthcare
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Movement Disorders

Start date: 2023-04-24
Primary completion: 2024-06-08
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.